← All news
Markets
Argenx shares jump after positive Phase 3 results in autoimmune myositis trial
2 outlets - including Investing and Seekingalpha - are covering this story.
Covered by 2 outlets
All coverage · 3 articles
Seeking Alpha
·Aug 18, 14:02 UTC
argenx SE (ARGX) Discusses Positive Phase 3 ALKIVIA Trial Results for VYVGART Hytrulo in Autoimmune Myositis Transcript
Investing.com News
·Aug 17, 10:04 UTC
Zai Lab, argenx report positive phase 3 data for myositis drug
Investing.com UK
·Aug 17, 07:24 UTC